As previous studies revealed that an increased tumor lesion HLA-F expression has been associated with poor prognosis in patients with gliomas (71), nasopharyngeal carcinoma (26), stage II breast cancer (72), and esophageal squamous cell carcinoma (19). The gene discussed is HLA-F; the disease is glioma.